-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on RXO, Raises Price Target to $17

Benzinga·03/04/2026 14:59:33
Listen to the news
Barclays analyst Brandon Oglenski maintains RXO (NYSE:RXO) with a Overweight and raises the price target from $15 to $17.